High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.
about
Hypercholesterolemia Tunes Hematopoietic Stem/Progenitor Cells for Inflammation and AtherosclerosisHigh density lipoprotein and metabolic disease: Potential benefits of restoring its functional propertiesHDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation.The Combination Therapy of Fenofibrate and Ezetimibe Improved Lipid Profile and Vascular Function Compared with Statins in Patients with Type 2 Diabetes.Impact of cholesterol on disease progressionBeta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice.Binding Characteristics of Sphingosine-1-Phosphate to ApoM hints to Assisted Release Mechanism via the ApoM Calyx-Opening.iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis.Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.Endothelial dysfunction and vascular disease - a 30th anniversary update.Pharmacological evidence for a role of the transient receptor potential canonical 3 (TRPC3) channel in endoplasmic reticulum stress-induced apoptosis of human coronary artery endothelial cells.Vascular protection by high-density lipoprotein-associated sphingosine-1-phosphate.Maternal supraphysiological hypercholesterolemia associates with endothelial dysfunction of the placental microvasculature.Biological recognition of graphene nanoflakes.Type 2 diabetes is associated with loss of HDL endothelium protective functions.
P2860
Q26742064-644035E6-EF7F-4143-8E4B-2231A76919AAQ26750603-106B6A0A-32CA-4212-826F-3EBCFD3F203EQ30251918-0AF0716C-4241-4F2D-97BC-A089FA2B6F9FQ33918771-79DCE50E-795C-4A46-A4B9-1DDE76401DEDQ35850911-0DB03242-897F-48C5-A9A9-9F2A77CBF32BQ36361831-CF4A6C28-5BBB-45F8-B62C-FAB2F2C97588Q37141279-9A91E856-85AD-4D7A-B4ED-404830465C94Q37236242-30AFDFED-B3C2-4541-83C9-A422F2A324C3Q37251396-2B782820-BF83-4C87-978C-1F0066B44687Q38680112-C8E13541-C2DA-42CE-AB4F-86995CF6913BQ38848833-F1617AAE-895B-4C69-9F2F-CD47CF7D8AE3Q47288414-7403492E-B337-4A45-8342-597061A63873Q54963510-F3B15626-DC63-4EA3-A2BC-C05CB30AD383Q55240345-AC5A489C-F9CD-4BFA-96F3-DCB9AAE66A02Q55246792-051430F6-2BE2-4BF9-9893-3570BD8D51C7
P2860
High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
High-density lipoproteins as m ...... with coronary artery disease.
@en
type
label
High-density lipoproteins as m ...... with coronary artery disease.
@en
prefLabel
High-density lipoproteins as m ...... with coronary artery disease.
@en
P2860
P356
P1476
High-density lipoproteins as m ...... with coronary artery disease.
@en
P2093
Adelheid Kratzer
Hector Giral
P2860
P304
P356
10.1093/CVR/CVU139
P577
2014-06-15T00:00:00Z